TrialEBioMedicine2022

Combining SJ733, an oral ATP4 inhibitor of Plasmodium falciparum, with the pharmacokinetic enhancer cobicistat: An innovative approach in antimalarial drug development.

Aditya H Gaur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.